BIOG-B:STO
BioGaia AB
SEK 116,80
arrow_upward
+1,21%(+1,40) 1D
9 okt, 17:29:57 GMT+2 · SEK
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor BIOG-B genereren…
Openen
SEK 116,20
Hoog
SEK 117,90
Laag
SEK 116,00
Beursw.
11,50 mld.
Gem. vol.
162,09K
Volume
58,09K
52 wk hoog
SEK 136,30
52 wk laag
SEK 96,20
Uitstaande aandelen
98,50 mln.
Aantal medewerkers
251
Openen
SEK 116,20
Hoog
SEK 117,90
Laag
SEK 116,00
Beursw.
11,50 mld.
Gem. vol.
162,09K
Volume
58,09K
52 wk hoog
SEK 136,30
52 wk laag
SEK 96,20
Uitstaande aandelen
98,50 mln.
Aantal medewerkers
251
Nieuwsartikelen
Van webbronnen en nieuwspartners
TipRanks
·
2 dagen geleden
BioGaia Sets October 22 Date for Q3 2026 Results and Investor Briefing
Profiel
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
Over BioGaia AB